Morgan Stanley Hikes Cerebras Price Target to $273 on Strong Q1

Morgan Stanley raised its price target on Cerebras Systems Inc. (NASDAQ:CBRS) to $273 from $250, maintaining an Overweight rating, following what the firm called "a strong first quarter out of the gates."

Rating Change

Previously, the price target was $250 with an Overweight rating. After the revision, the price target is $273 with the same Overweight rating.

Analyst's Rationale

The Morgan Stanley analyst believes Cerebras' first-quarter results exceeded expectations, boosting confidence in the company's ability to compete in the AI chip market. The analyst also noted sustained strong demand for its products.

Context

Cerebras is a rising player in the AI chip space, attracting investor attention since its IPO. Other analysts are cautiously optimistic, though competition with NVIDIA (NVDA) and AMD (AMD) remains intense.

What to Make of It

The price target hike reflects near-term optimism, but investors should weigh this against competitive risks in the market.